Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lea Reg was a private medical device and in vitro diagnostics regulatory services company focused on helping device manufacturers comply with national registration and local representative requirements. The company acted as a designated local representative or agent for medical device and IVD companies and also offered services related to device importing, exporting, and regulatory support. Available sources describe it as a for-profit healthcare-related company rather than a therapeutics developer, with no disclosed drug pipeline. Lea Reg was acquired by Veranex in October 2022 for an undisclosed amount, and third-party databases now list its operating status as closed or acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lea Reg.